Second-line afatinib administration in an elderly patient with squamous cell carcinoma

INTRODUCTION: The majority of cases of lung cancer are still diagnosed at a late stage. At this stage, palliative therapeutic options including nonspecific cytotoxic drugs, targeted therapy, or immunotherapy can be utilized. In 2016, immunotherapy was approved in Europe for squamous cell carcinoma a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Paul, Steinheimer, Michael, Benhassen, Naim, Sardeli, Chrysanthi, Stalikas, Nikos, Toitou, Melpomeni, Huang, Haidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367451/
https://www.ncbi.nlm.nih.gov/pubmed/28356747
http://dx.doi.org/10.2147/TCRM.S130816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367451/
https://www.ncbi.nlm.nih.gov/pubmed/28356747
http://dx.doi.org/10.2147/TCRM.S130816

Ejemplares similares